Stockreport

BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26

BeOne Medicines Ltd. - American Depositary Shares  (ONC) 
PDF SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its fourth quarter and full [Read more]